MedTrace Logo

Botulinum Toxin for Carpal Tunnel Syndrome

NCT00701233 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2019-04-17

No results posted yet for this study

Summary

To compare local steroid injections to local Botulinum toxin A injection in a double-blinded study.

Conditions

  • Carpal Tunnel Syndrome

Interventions

DRUG

Botulinum toxin

45 units Botox injected into Carpal Tunnel once

DRUG

Corticosteroid injection into Carpal Tunnel

40 mg Triamcinolone with one mL 1% lidocaine injected once into Carpal Tunnel

Sponsors & Collaborators

Principal Investigators

  • Dennis Dykstra, MD · University of Minnesota

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2018-10-31
Completion
2018-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00701233 on ClinicalTrials.gov